Creon: Pancreatic enzyme replacement therapy shortages lead to “concern and anxiety”
A continuing shortage of the pancreatic enzyme replacement therapy (PERT) medication, Creon, within the UK, is generating “deep concern and anxiety” among patients, healthcare professionals, and pharmacists, various representative groups have cautioned. Earlier this May, the Department of Health and Social Care issued a national alert related to patient safety regarding the scarcity of Creon, a drug prescribed to manage pancreatic exocrine insufficiency in individuals suffering from conditions
3519 likes
122 650 views
